dc.contributor |
Medecins sans Frontieres, Thyolo District, Malawi. |
|
dc.creator |
Buhendwa, L |
|
dc.creator |
Zachariah, R |
|
dc.creator |
Teck, R |
|
dc.creator |
Massaquoi, M |
|
dc.creator |
Kazima, J |
|
dc.creator |
Firmenich, P |
|
dc.creator |
Harries, A D |
|
dc.date |
2008-01 |
|
dc.date.accessioned |
2017-01-31T07:10:36Z |
|
dc.date.available |
2017-01-31T07:10:36Z |
|
dc.identifier |
Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmission programme in rural Malawi. 2008, 38 (1):30-2notTrop Doct |
|
dc.identifier |
0049-4755 |
|
dc.identifier |
18302861 |
|
dc.identifier |
10.1258/td.2007.060091 |
|
dc.identifier |
http://hdl.handle.net/10144/22672 |
|
dc.identifier |
http://fieldresearch.msf.org/msf/handle/10144/22672 |
|
dc.identifier |
Tropical Doctor |
|
dc.identifier.uri |
http://dspace.mediu.edu.my:8181/xmlui/handle/10144/22672 |
|
dc.description |
This study shows that cabergoline (single oral-dose) is an acceptable, safe and effective drug for suppressing puerperal lactation. It could be of operational benefit not only for artificial feeding, but also for weaning in those that breast-feed within preventive mother-to-child HIV transmission programmes in resource-limited settings. |
|
dc.language |
en |
|
dc.publisher |
Royal Society of Medicine |
|
dc.relation |
http://td.rsmjournals.com |
|
dc.rights |
Reproduced on this site with the permission of Royal Society of Medicine Press, London ([url]http://www.rsmpress.co.uk/td.htm[/url]) |
|
dc.title |
Cabergoline for suppression of puerperal lactation in a prevention of mother-to-child HIV-transmission programme in rural Malawi. |
|